Showing results (221-230 of 387) with videos related to

Sort By:
Pageof 39
Applied and Environmental Microbiology|November 28, 2001
Efficient homolactic fermentation by Kluyveromyces lactis strains defective in pyruvate utilization and transformed with the heterologous LDH geneM M Bianchi, L Brambilla, F Protani, et al.
Analytical and Bioanalytical Chemistry|May 17, 2011
Terracotta polychrome sculptures examined before and after their conservation work: contributions from non-invasive in situ analytical techniquesC Colombo, F Bevilacqua, L Brambilla, et al.
Breast Cancer Research and Treatment|January 1, 1996
Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinomaP Bevilacqua, P Verderio, M Barbareschi, et al.
European Journal of Dermatology : EJD|February 29, 2000
Coagulation factor XIII, endothelial damage and systemic sclerosisA V Marzano, A B Federici, G Gasparini, et al.
British Journal of Cancer|November 1, 1992
Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancerG Gasparini, P Bevilacqua, F Pozza, et al.
Journal of Nephrology|November 4, 2000
Acute renal failure due to idiopathic tubulo-intestinal nephritis and uveitis: "TINU syndrome". Case report and review of the literatureA Sessa, M Meroni, G Battini, et al.
Dermatology (Basel, Switzerland)|September 11, 2001
Human herpesvirus 8 DNA in the skin and blood of patients with Mediterranean Kaposi's sarcoma: clinical correlationsV Boneschi, L Brambilla, E Berti, et al.
Tumori|December 31, 1992
Surgical and adjuvant radiation therapy of resectable retroperitoneal soft tissue sarcomas in adultsA Testolin, F Pozza, S Dal Fior, et al.
International Journal of Cancer|March 3, 1995
67-kDa laminin-receptor expression adds prognostic information to intra-tumoral microvessel density in node-negative breast cancerG Gasparini, M Barbareschi, P Boracchi, et al.
European Review for Medical and Pharmacological Sciences|November 30, 2022
Improvement in health status and quality of life in patients with osteoporosis treated with denosumab: results at a mean follow-up of six yearsM Mercurio, F Familiari, R de Filippis, et al.
Pageof 39